Novartis buys 25% of Alcon; exercises option for 52% more
- OTC, Consumer
- Implantable Devices
- Surgical Equipment & Devices
- Full Acquisition
- Includes Contract
- Payment Includes Cash
Please contact Sales at: (212) 520-2765 or email [email protected]
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.